Holen Sie sich die Stockscreener-App
3.03
0.00%
0.00
Schlusskurs vom Vortag:
$3.03
Offen:
$3.05
24-Stunden-Volumen:
110.82K
Relative Volume:
0.50
Marktkapitalisierung:
$121.71M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-1.3467
EPS:
-2.25
Netto-Cashflow:
$-44.47M
1W Leistung:
+4.48%
1M Leistung:
+5.94%
6M Leistung:
-48.21%
1J Leistung:
-39.03%
1-Tages-Spanne:
$2.98
$3.13
1-Wochen-Bereich:
$2.82
$3.13
52-Wochen-Spanne:
$2.30
$7.84
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
3.03 | 121.71M | 63.15M | -40.30M | -44.47M | -2.25 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Australia
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance Australia
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
TELA Bio Reports Third Quarter 2024 Financial Results - The Manila Times
What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings - GuruFocus.com
TELA Bio Announces Inducement Grants of Restricted Stock Units to New Employees - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio (TELA) to Release Quarterly Earnings on Thursday - MarketBeat
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio - MSN
Stonepine Capital Management, LLC Increases Stake in TELA Bio Inc - GuruFocus.com
TELA Bio, Inc. Discloses Preliminary Financial Results for the Third Quarter - Defense World
Insiders Of TELA Bio Reap Rewards After Their Investment Jumps Another US$69k - Simply Wall St
Antony Koblish Bought 42% More Shares In TELA Bio - Yahoo Finance
OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc - Yahoo Finance
Tela Bio's chief technology officer buys $49,999 in stock By Investing.com - Investing.com Canada
Insider Buying: CTO Paul Talmo Acquires 22,222 Shares of TELA Bi - GuruFocus.com
Tela Bio's chief commercial officer Gregory Firestone buys $14,998 in stock - Investing.com
Tela bio COO and CFO Roberto Cuca acquires $144,999 in stock - Investing.com
Insider Purchase: Chief Commercial Officer Gregory Firestone Acq - GuruFocus.com
Insider Buying Alert: CFO Roberto Cuca Acquires Shares of TELA B - GuruFocus.com
TELA Bio, Inc. (NASDAQ:TELA) Insider Purchases $14,998.50 in Stock - MarketBeat
Tela Bio's chief technology officer buys $49,999 in stock - Investing.com
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):